Published in Clin Exp Immunol on June 01, 1993
Adhesion molecules in inflammatory bowel disease. Gut (1995) 1.36
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol (1994) 1.15
Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol (1995) 1.12
Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis (2002) 1.09
Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol (2010) 1.00
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther (2004) 0.92
Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol (1997) 0.91
Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis. Mol Pathol (1997) 0.87
Circulating adhesion molecules in sarcoidosis. Clin Exp Immunol (1994) 0.83
Tumour necrosis factor alpha stimulated rheumatoid synovial microvascular endothelial cells exhibit increased shear rate dependent leucocyte adhesion in vitro. Ann Rheum Dis (1999) 0.83
Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis (2002) 0.81
Markers of childhood lupus nephritis indicating disease activity. Pediatr Nephrol (2010) 0.80
Lymphocyte phenotypes in wild-caught rats suggest potential mechanisms underlying increased immune sensitivity in post-industrial environments. Cell Mol Immunol (2012) 0.80
Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: relationship to soluble adhesion molecules and extraarticular manifestations. Rheumatol Int (2007) 0.79
Molecular characterization of rheumatoid arthritis with magnetic resonance imaging. Top Magn Reson Imaging (2011) 0.79
Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE. Lupus (2014) 0.79
Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma. Clin Exp Immunol (1995) 0.77
Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results. Rheumatol Int (2005) 0.76
Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1. Leukemia (2016) 0.76
A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil Infiltration during Acute Lung Injury. J Immunol (2016) 0.75
Cell adhesion molecules in subretinal fluid: soluble forms of VCAM-1 (vascular cell adhesion molecule-1) and L-selectin. Int Ophthalmol (1999) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell (1989) 9.06
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med (1990) 3.55
Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol (1991) 2.98
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science (1990) 2.69
Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest (1991) 2.59
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol (1990) 2.55
IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol (1990) 2.15
Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet (1991) 1.95
Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol (1991) 1.59
Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest (1993) 1.50
Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res (1991) 1.40
The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol (1991) 1.37
Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. Biochem Biophys Res Commun (1991) 1.37
Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum (1991) 1.35
Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant (1991) 1.30
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med (2013) 7.51
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Q J Exp Physiol Cogn Med Sci (1974) 2.65
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol (1990) 2.55
Association of maternal endothelial dysfunction with preeclampsia. JAMA (2001) 2.17
IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol (1990) 2.15
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol (1992) 2.12
The effects of proteins upon the filtration coefficient of individually perfused frog mesenteric capillaries. Microvasc Res (1977) 1.89
IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol (1990) 1.86
Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation (2000) 1.71
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Spontaneous rupture of the spleen in rheumatoid arthritis. Ann Rheum Dis (1983) 1.63
Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol (1991) 1.57
Osmotic reflextion coefficients of capillary walls to low molecular weight hydrophilic solutes measured in single perfused capillaries of the frog mesentery. J Physiol (1976) 1.56
Takayasu's arteritis--recent advances in imaging offer promise. Rheumatology (Oxford) (2006) 1.54
Renal disease associated with circulating antineutrophil cytoplasm activity. Q J Med (1992) 1.54
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clin Nephrol (2009) 1.51
Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med (1994) 1.51
Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor. J Cell Sci (2000) 1.50
Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest (1993) 1.50
Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum (1997) 1.42
Mechanisms of inflammation in gout. Rheumatology (Oxford) (2005) 1.42
Cyclosporin-induced muscular toxicity. Lancet (1990) 1.41
Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol (2001) 1.41
CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction. Am J Transplant (2013) 1.40
Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep (2001) 1.40
Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients. Eur J Clin Pharmacol (2004) 1.39
The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol (1991) 1.37
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation (2001) 1.32
The ultrastructure of frog mesenteric capillaries of known filtration coefficient. Q J Exp Physiol Cogn Med Sci (1979) 1.31
Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant (1991) 1.30
Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors (2001) 1.30
Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol (1999) 1.30
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int (2000) 1.25
Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol (1994) 1.23
The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther (2009) 1.22
Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22
Evolution, stress, and longevity. J Anat (2000) 1.22
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant (2007) 1.22
Hearing results after primary cartilage tympanoplasty. Laryngoscope (2000) 1.21
Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis (2004) 1.21
Giant cell arteritis. BMJ (1992) 1.19
Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.17
Differential upregulation of intercellular adhesion molecule-1 in coeliac disease. Clin Exp Immunol (1990) 1.16
TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol (1999) 1.13
Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease. J Clin Pathol (1991) 1.13
Referral of elderly patients with severe renal failure: questionnaire survey of physicians. BMJ (1996) 1.12
Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol (1995) 1.12
Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies. J Invest Dermatol (1987) 1.11
The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg (2001) 1.11
Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood (1999) 1.10
Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant (2007) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Expression of adhesion molecules in human intestinal graft-versus-host disease. Clin Exp Immunol (1992) 1.08
Ethnicity and clinical care: Indians. Physician Assist Health Pract (1980) 1.07
The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol (1992) 1.05
Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol (2006) 1.05
Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J Immunol (1999) 1.04
Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol (1997) 1.03
An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg (2000) 1.03
Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence. J Immunol (1999) 1.03
Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells. J Leukoc Biol (2008) 1.03
Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum (1996) 1.03
Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther (1997) 1.02
Interaction of cyclosporin and ticlopidine. Nephrol Dial Transplant (1991) 1.02
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant (2010) 1.01
An integrated approach to studying regulation of production of the antibiotic methylenomycin by Streptomyces coelicolor A3(2). J Bacteriol (1992) 0.99
Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study. Lupus (2009) 0.98
Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res (1991) 0.98
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. Am J Transplant (2009) 0.97
Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant (2009) 0.96
Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium. J Immunol (1994) 0.96
Effect of aprotinin on endothelial cell activation. J Thorac Cardiovasc Surg (2001) 0.96
T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells. Immunology (1990) 0.96
Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C. J Immunol (1996) 0.95
The inflammatory effect of cardiopulmonary bypass on leukocyte extravasation in vivo. J Thorac Cardiovasc Surg (2008) 0.95
Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma. Oncogene (2012) 0.95
Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. J Rheumatol (1991) 0.94
Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology (Oxford) (2002) 0.94
Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis. Arthritis Rheum (2001) 0.94
The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg (2000) 0.94
Gold exacerbates adjuvant arthritis in the rat. Ann Rheum Dis (1984) 0.93